Speakers:

Cihan Ay "Cancer and VTE: mechanistic underpinnings of risk"

Cancer is a strong and independent risk factor for thrombosis. The epidemiology, risk factors and molecular mechanisms of cancer-associated thrombosis (CAT) differ from venous thromboembolism in the general population.

 

Marc Carrier "Medical treatment of cancer-associated VTE in 2018"

Recent clinical trials have assessed the role of direct oral anticoagulants (DOACs) for the management of cancer-associated thrombosis (CAT).

 

Moderator:

Tzu-Fei Wang

 

 

Supported by an unrestricted educational grant from: Bayer

Session date: 
Wednesday, November 28, 2018 - 10:30am to 11:30am
Location: 
ISTH Webinar Library
Carrboro, NC 27510
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.